收藏切换
A case report of fatal traumatic brain injury complicated by propofol infusion syndrome
收藏切换
PDF
Xu GAO1a, Xing-hong LI1b, Xiao-yu JÜ1a, Wen-xi ZHANG1a, Jie CHENG1a
Chinese Journal of Clinical Pharmacology | 2025, 41(21) : 3120 - 3124
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(21): 3120-3124
Medication Comment
A case report of fatal traumatic brain injury complicated by propofol infusion syndrome
Full
Xu GAO1a, Xing-hong LI1b, Xiao-yu JÜ1a, Wen-xi ZHANG1a, Jie CHENG1a
Affiliations
  • 1a.Department of Pharmacy, Hebei Provincial Hospital of Traditional Chinese Medicine, Hebei Industrial Technology Institute for Traditional Chinese Medicine, Key Laboratory of Evaluation and Transformation of Traditional Chinese Medicine Under Hebei Provincial Administration of Traditional Chinese Medicine, Shijiazhuang 050000, Hebei Province, China
  • 1b.Department of Neurosurgery, Hebei Provincial Hospital of Traditional Chinese Medicine, Hebei Industrial Technology Institute for Traditional Chinese Medicine, Key Laboratory of Evaluation and Transformation of Traditional Chinese Medicine Under Hebei Provincial Administration of Traditional Chinese Medicine, Shijiazhuang 050000, Hebei Province, China
Published: 2025-11-17 doi: 10.13699/j.cnki.1001-6821.2025.21.020
Outline
收藏切换

A 55 years old female patient was given propofol medium and long chain fat emulsion injection once, during the operation due to traumatic brain injury (TBI), with no documented adverse drug reactions (ADRs). Postoperative cerebral edema was treated with propofol injectable emulsion sedation to lower intracranial pressure. One day after medication initiation, the patient developed oliguria, darkened urine, elevated creatine kinase, elevated transaminases and electrocardiogram (ECG) changes. The patient responded poorly to fluid resuscitation and hepatoprotective therapy, leading to a presumptive diagnosis of propofol infusion syndrome (PRIS). Three days later withdrawal of propofol symptomatic treatment were administered. The patient’s symptoms and laboratory tests improved, but later death due to heart arrest. This case serves as a reminder that clinicians should be vigilant about the cumulative dose and infusion duration of propofol when treating critically ill patients. The absence of ADRs with previous use don’t entirely preclude the risk of subsequent administration. Early recognition of PRIS is critical. Once patients experience symptoms such as unexplained creatine kinase elevation and ECG changes, early diagnosis, timely drug withdrawal and symptomatic treatment measures such as hemofiltration should be taken to ensure medication safety.

propofol  /  infusion syndrome  /  traumatic brain injury  /  death  /  adverse drug reaction
Xu GAO, Xing-hong LI, Xiao-yu JÜ, Wen-xi ZHANG, Jie CHENG. A case report of fatal traumatic brain injury complicated by propofol infusion syndrome[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (21) : 3120 -3124 . DOI: 10.13699/j.cnki.1001-6821.2025.21.020
Year 2025 volume 41 Issue 21
PDF
597
487
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.21.020
  • Receive Date:2025-07-16
  • Online Date:2026-08-05
  • Published:2025-11-17
Article Data
Affiliations
History
  • Received:2025-07-16
Affiliations
    1a.Department of Pharmacy, Hebei Provincial Hospital of Traditional Chinese Medicine, Hebei Industrial Technology Institute for Traditional Chinese Medicine, Key Laboratory of Evaluation and Transformation of Traditional Chinese Medicine Under Hebei Provincial Administration of Traditional Chinese Medicine, Shijiazhuang 050000, Hebei Province, China
    1b.Department of Neurosurgery, Hebei Provincial Hospital of Traditional Chinese Medicine, Hebei Industrial Technology Institute for Traditional Chinese Medicine, Key Laboratory of Evaluation and Transformation of Traditional Chinese Medicine Under Hebei Provincial Administration of Traditional Chinese Medicine, Shijiazhuang 050000, Hebei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.21.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT